Michelle Fang Jordan joined Athyrium in 2015 and currently serves as a Principal. Michelle is responsible for all aspects of the investment process from sourcing, due diligence, deal execution, monitoring to exit strategy. Michelle has played a key role in the firm’s structured credit and equity investments in specialty therapeutics and payor and provider technology and services.

Previously, she was an Associate Consultant at L.E.K. Consulting where she performed commercial due diligence and strategy projects for healthcare companies and private equity investors.

Michelle graduated magna cum laude from the University of Pennsylvania with a B.A. in Health and Societies with a concentration in health care economics and a minor in Biology.